Yahoo Finance • 6 days ago
The European market has shown resilience, with the pan-European STOXX Europe 600 Index rising by 1.03% amid expectations of a U.S. Federal Reserve interest rate cut, signaling optimism in the region's economic outlook despite some mixed si... Full story
Yahoo Finance • 21 days ago
[Businessmen making handshake with partner, greeting, dealing, merger and acquisition, business cooperation concept, for business, finance and investment background, teamwork and successful business] Tippapatt PHC Holdings (OTCPK:PHCCF [h... Full story
Yahoo Finance • 22 days ago
CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organ... Full story
Yahoo Finance • 29 days ago
[Sign for Wall Street in New York City] Pharrel Wiliams Bioengineered tissue maker Humacyte (NASDAQ:HUMA [https://seekingalpha.com/symbol/HUMA]) and Senseonics (NYSE:SENS [https://seekingalpha.com/symbol/SENS]), a developer of continuous... Full story
Yahoo Finance • last month
Investing.com - Berenberg downgraded Sensirion AG (SIX:SENS) from Buy to Hold on Wednesday, while lowering its price target to CHF81.00 from CHF85.00, following the stock’s 36% rise since the beginning of the year. The Swiss sensor manufa... Full story
Yahoo Finance • last month
Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Meter Data Management System Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. The Meter Da... Full story
Yahoo Finance • 2 months ago
Investing.com - Raymond James maintained its Underperform rating on Senseonics Holdings (NYSE:SENS) on Friday, with no change to its price target. The stock, currently trading at $0.49, has fallen over 55% in the past six months, with Inve... Full story
Yahoo Finance • 2 months ago
Earnings Call Insights: Senseonics Holdings, Inc. (SENS) Q2 2025 MANAGEMENT VIEW * CEO Timothy T. Goodnow indicated, "In the second quarter, we executed on a number of programs to drive shareholder value and position Senseonics for lon... Full story
Yahoo Finance • 2 months ago
Generated Q2 revenue of $6.6 million, representing year-over-year growth of 37% Achieved a 79% increase in U.S. new patient starts over prior year GERMANTOWN, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE Ameri... Full story
Yahoo Finance • 2 months ago
Fully integrated, factory-tested system delivers higher reliability, faster installation and lower total cost of ownership compared to traditional engine starting solutions SuperTorque 8ZRSuperTorque 8ZR is the preassembled, UL-listed sys... Full story
Yahoo Finance • 2 months ago
Investing.com - Senseonics Holdings (NYSE:SENS) stock, currently trading at $0.57, received its first coverage from Lake Street Capital Markets on Thursday, with the research firm assigning a Buy rating and a $1.00 price target. According... Full story
Yahoo Finance • 3 months ago
Investing.com - H.C. Wainwright raised its price target on Senseonics Holdings (NYSE:SENS) to $1.40 from $1.10 on Tuesday, while maintaining a Buy rating on the diabetes technology company. Currently trading at $0.49, SENS has analyst targ... Full story
Yahoo Finance • 7 months ago
Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system SweetSpot partners with endocrinology practices to provide virtual CGM monitoring and enhanced patient care GE... Full story
Yahoo Finance • 3 years ago
Senseonics, PHC Holdings Corporation and Ascensia Diabetes Care Joint Eversense CGM Virtual Analyst and Investor Event to begin March 15th, 2023 at 6:30pm ET GERMANTOWN, Md., March 15, 2023--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYS... Full story
Yahoo Finance • 3 years ago
GERMANTOWN, Md., April 26, 2022--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM)... Full story